Antibodies reveal rheumatoid arthritis before it breaks outNovember 10, 2003Now patients with rheumatoid arthritis (RA) can be diagnosed considerably earlier, thereby increasing their chances of being treated successfully. This is a consequence of new findings by Professor Solbritt Rantap'¤'¤-Dahlqvist's research team at the Unit for Rheumology, Department of Public Health and Clinical Medicine, Ume'å University in Sweden. Rheumatoid arthritis, also known as arthritic rheumatism, is a severe disease where the body's immune defense system attacks the body's own joint cartilage. In many cases the disease leads to severe pain and crippled joints, above all in the hands and fingers. Hereditary factors have been shown to be important in how the disease develops. The discovery that patients with rheumatoid arthritis develop antibodies against citrullin (CCP) several years before the onset of the disease represents a new way to diagnose the disorder long before it breaks out. This means that treatment can be introduced even before the patient experiences any symptoms, by so-called screening of middle-aged people with RA in the family. Rantap'¤'¤-Dahlqvist's study was published in the October issue of Arthritis & rheumatism, which is the highest ranked rheumatology journal in the world. The title of the article is "Antibodies against Cyclic Citrullinated Peptide (CCP) and Immunoglobulin-A Rheumatoid Factor predict the development of Rheumatoid Arthritis," and it has already attracted international attention. | |||||||||||||||||||||
|
Related Arthritis News Articles Study shows pine bark naturally reduces knee osteoarthritis According to the Center for Disease Control (CDC), osteoarthritis, the most common type of arthritis, is on the rise. A new study published in the August journal of Phytotherapy Research, reveals Pycnogenol, bark extract from the French maritime pine tree, reduced overall knee osteoarthritis (OA) symptoms by 20.9 percent and lowered pain by 40.3 percent. Loss of sleep, even for a single night, increases inflammation in the body Loss of sleep, even for a few short hours during the night, can prompt one's immune system to turn against healthy tissue and organs. Nearly half of U.S. adults will develop painful knee osteoarthritis by age 85: study Almost half of all U.S. adults and nearly two-thirds of obese adults will develop painful osteoarthritis of the knee by age 85, a study based at the University of North Carolina at Chapel Hill suggests. Cell removal technique could lead to cheaper drugs Researchers at the University of Edinburgh have pioneered a simple way to remove dead cells from cell cultures used to make protein-based drugs, which are increasingly prescribed to treat a range of illnesses. New study shows health benefits of probiotic could extend to the entire body Data from a recent study demonstrate the anti-inflammatory and pathogen protection benefits of Bifidobacterium infantis 35624 a probiotic bacterial strain of human origin. Bone marrow stem cells may help control inflammatory bowel disease Massachusetts General Hospital (MGH) investigators have found that infusions of a particular bone marrow stem cell appeared to protect gastrointestinal tissue from autoimmune attack in a mouse model. Researchers discover how rheumatoid arthritis causes bone loss Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry. New test to diagnose osteoarthritis early A newly developed medical imaging technology may provide doctors with a long-awaited test for early diagnosis of osteoarthritis (OA), scientists from New York reported today at the 236th National Meeting of the American Chemical Society. NIH scientists find a novel mechanism that controls the development of autoimmunity Scientists at the National Institutes of Health (NIH) have found a mechanism in the immune systems of mice that can lead to the development of autoimmune disease when turned off. Protein complementarity may offer new insights into autoimmune diseases The discovery of "complementary" antibodies against plasminogen in patients with blood vessel inflammation caused by anti-neutrophil cytoplasmic autoantibodies (ANCAs) may lead to new approaches to research, testing, and treatment of ANCA vasculitis and other autoimmune diseases, suggests a paper in the December Journal of the American Society of Nephrology (JASN). More Arthritis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||